Back to search
Valsartan for prevention of restenosis after stenting of type B2/C lesions: the VAL-PREST trial.
Data up to Jan 2025
Published2001
Citations135
References0
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
Loading...